Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Pilar Lim, PhD
JCP
Original Research
Esketamine Nasal Spray Rapidly Reduces Depression
May 12, 2020
There is an unmet need in patients with depression and active suicidal ideation for new therapies that can rapidly bridge the gap until antidepressants take effect. Read this article...
Dong-Jing Fu
,
Dawn F. Ionescu
,
Xiang Li
, et al
JCP
Original Research
Esketamine Nasal Spray Plus for Depression
April 28, 2020
Read a study about esketamine nasal spray (oral antidepressant) and it's long-term safety, tolerability, and efficacy for treatment-resistant depression (TRD).
Ewa Wajs
,
Leah Aluisio
,
Richard Holder
, et al
JCP
Article
Consensus Recommendations for Assessing Suicidal Ideation and Behavior
June 28, 2017
Industry experts gathered to develop guidance for standardized data collection and analysis of suicidal ideation and to guide the development of novel treatments in an effort to rectify the...
Phillip B. Chappell
,
Michelle Stewart
,
Larry Alphs
, et al